Edition:
United States

Abbott Laboratories (ABT.N)

ABT.N on New York Stock Exchange

68.97USD
3:17pm EDT
Change (% chg)

$0.47 (+0.69%)
Prev Close
$68.50
Open
$68.63
Day's High
$69.01
Day's Low
$68.40
Volume
573,301
Avg. Vol
1,447,046
52-wk High
$69.01
52-wk Low
$51.38

Summary

Name Age Since Current Position

Miles White

63 1999 Chairman of the Board, Chief Executive Officer

Brian Yoor

49 2017 Chief Financial Officer, Executive Vice President - Finance

Michael Rousseau

63 2017 President - Cardiovascular and Neuromodulation

Hubert Allen

52 2013 Executive Vice President, General Counsel, Secretary

Stephen Fussell

60 2013 Executive Vice President - Human Resources

Robert Ford

44 2015 Executive Vice President - Medical Devices

Jaime Contreras

61 2013 Senior Vice President - Core Laboratory Diagnostics, Commercial Operations

Eric Fain

57 2017 Senior Vice President, Group President - Cardiovascular and Neuromodulation

Daniel Salvadori

39 2014 Senior Vice President - Established Pharmaceuticals, Latin America.

William Osborn

70 2013 Lead Independent Director

John Stratton

57 2017 Director

Robert Alpern

67 2008 Independent Director

Roxanne Austin

57 2000 Independent Director

Sally Blount

56 2011 Independent Director

Edward Liddy

72 2010 Independent Director

Nancy McKinstry

59 2011 Independent Director

Phebe Novakovic

60 2010 Independent Director

Samuel Scott

73 2007 Independent Director

Daniel Starks

63 2017 Independent Director

Glenn Tilton

69 2007 Independent Director

Biographies

Name Description

Miles White

Mr. Miles D. White serves as Chairman of the Board, Chief Executive Officer of the Company. Mr. White has served as Abbott's Chairman of the Board and Chief Executive Officer since 1999. He served as an Executive Vice President of Abbott from 1998 to 1999. He joined Abbott in 1984. He currently serves as a Director of Caterpillar Inc. and McDonald's Corporation. Serving as Abbott's Chairman of the Board and Chief Executive Officer since 1999 and having joined Abbott in 1984, Mr. White contributes not only his valuable business, management and leadership experience, but also his extensive knowledge of the Company and its global operations, as well as key insights into strategic, management and operation matters, ensuring the appropriate level of oversight and responsibility is applied to all Board decisions.

Brian Yoor

Mr. Brian B. Yoor serves as Chief Financial Officer, Executive Vice President - Finance of the Company. Brian joined Abbott in August 1997, and held various financial management positions of increasing responsibility, including Controller positions in the pharmaceutical, nutrition, and diagnostic businesses, before being asked to lead Abbott’s Investor Relations effort in January 2013. He became Abbott’s Chief Financial Officer in June 2015. Prior to joining Abbott, Brian was a certified public accountant with Arthur Andersen and held financial positions in the consumer industry with the Scotts Company and Newell Rubbermaid. "In Abbott Finance, we are the stewards that enable financial reliability and growth for Abbott," says Brian. "A strong, growing company is better able to help people around the world live their healthiest lives." Brian serves on the board of the Clara Abbott Foundation. He is a member of the CNBC Global CFO Council. He earned his bachelor’s degree in accounting at the University of Toledo in Ohio.

Michael Rousseau

Mr. Michael T. Rousseau is President - Cardiovascular and Neuromodulation of the Company. From 2016 to 2017 — President and Chief Executive Officer, St. Jude Medical, Inc. (a global medical device manufacturer). And also 2014 to 2015 — Chief Operating Officer, St. Jude Medical, Inc. He was from 2012 to 2014 — Group President, Cardiovascular and Ablation Technologies Division, Implantable Electronic Systems Division and U.S. Division, St. Jude Medical, Inc. He was 2009 to 2012 — Group President, Cardiac Rhythm Management Division, Neuromodulation Division, Atrial Fibrillation Division, Cardiovascular Division and U.S. Division, St. Jude Medical, Inc.

Hubert Allen

Mr. Hubert L. Allen is Executive Vice President, General Counsel and Secretary of the Company. From 2010 to 2012 — Divisional Vice President and Associate General Counsel, Established Pharmaceuticals; 2009 to 2010 — Divisional Vice President and Associate General Counsel, Proprietary Pharmaceuticals; 2007 to 2009 — Section Head, Legal, Abbott Nutrition. He is Elected Corporate Officer in 2012

Stephen Fussell

Mr. Stephen R. Fussell is Executive Vice President - Human Resources of the Company. Previously, he served as Vice President, Compensation and Development. Mr. Fussell joined Abbott in 1996, as Divisional Vice President, Compensation and Benefits. Prior to joining Abbott, Mr. Fussell was Vice President, Total Compensation and Workforce Information at Nestlé USA. Mr. Fussell is a board member for the Clara Abbott Foundation and the Abbott Fund. He earned a Bachelor's degree in Management and Administration from Louisiana State University in Baton Rouge.

Robert Ford

Mr. Robert B. Ford is Executive Vice President - Medical Devices of the Company. He served as Senior Vice President, Diabetes Care of the Company between 2014 and 2015. From 2008 to 2014 — Vice President, Diabetes Care, Commercial Operations. He was elected Corporate Officer — 2008.

Jaime Contreras

Mr. Jaime Contreras is the Senior Vice President - Core Laboratory Diagnostics, Commercial Operations of the Company. From 2008 to 2013 he was Vice President, Diagnostics, Global Commercial Operations.

Eric Fain

Dr. Eric S. Fain, M.D., is Senior Vice President, Group President - Cardiovascular and Neuromodulation of the Company. From 2014 to 2017 — Group President, St. Jude Medical, Inc. (a global medical device manufacturer). And He was from 2012 to 2014 — President, Implantable Electronic Systems Division, St. Jude Medical, Inc. From 2012 to 2014 — Group President, Cardiovascular and Ablation Technologies Division, Implantable Electronic Systems Division and U.S. Division, St. Jude Medical, Inc. From 2007 to 2012 — President, Cardiac Rhythm Management Division, St. Jude Medical, Inc.

Daniel Salvadori

Mr. Daniel Gesua Sive Salvadori is Senior Vice President - Established Pharmaceuticals, Latin America of the Company. From 2013 to 2014 — Chief Executive Officer, Latin America, CFR Pharmaceuticals S.A. (a Latin American pharmaceutical company). From 2012 to 2013 — Executive President, Complex Therapeutics Division, CFR Pharmaceuticals S.A. From 2010 to 2012 — Head of Sales and Marketing, Latin America, Sandoz Pharmaceuticals, Novartis AG (a Swiss multinational pharmaceutical company). From 2009 to 2010 — Director of Global Strategy and Mergers and Acquisitions, Sandoz Pharmaceuticals, Novartis AG.

William Osborn

Mr. William A. Osborn serves as Lead Independent Director of the Company. Mr. Osborn was Chairman of Northern Trust Corporation from 1995 through 2009 and served as its Chief Executive Officer from 1995 through 2007. Mr. Osborn currently serves as a Director of Caterpillar Inc. and General Dynamics Corporation. Mr. Osborn served on the Board of Directors of Nicor, Inc. from 1999 to 2006 and on the Board of Directors of Tribune Company from 2001 to 2012. As the Chairman and Chief Executive Officer of Northern Trust Corporation and The Northern Trust Company, Mr. Osborn acquired broad experience in successfully overseeing complex global businesses operating in highly regulated industries.

John Stratton

Mr. JOHN G. STRATTON is Director of the Company. Mr. Stratton has served as Executive Vice President and President of Global Operations since February 2015. Previously, he served as Executive Vice President and President of Global Enterprise and Consumer Wireline from April 2014 to February 2015, as President of Verizon Enterprise Solutions from January 2012 to April 2014, and as Chief Operating Officer and Executive Vice President of Verizon Wireless from October 2010 to January 2012. Since October 2012, Mr. Stratton has also served as a member of The President's National Security Telecommunications Advisory Committee. Through his executive leadership at Verizon Communications, Mr. Stratton contributes extensive business and management experience operating a global public company such as Abbott, including valuable insights on corporate strategy and risk management. His service on the National Security Telecommunications Advisory Committee enables him to provide government perspective and experience in a highly regulated industry.

Robert Alpern

Dr. Robert J. Alpern, M.D. , serves as Independent Director of the Company. Dr. Alpern has served as the Ensign Professor of Medicine, Professor of Internal Medicine, and Dean of Yale School of Medicine since June 2004. From July 1998 to June 2004, Dr. Alpern was the Dean of The University of Texas Southwestern Medical Center. Dr. Alpern also serves as a Director of AbbVie Inc. and as a Director on the Board of Yale—New Haven Hospital. As the Ensign Professor of Medicine, Professor of Internal Medicine, and Dean of Yale School of Medicine, Dean of The University of Texas Southwestern Medical Center, and as a Director on the Board of Yale—New Haven Hospital, Dr. Alpern contributes valuable insights to the Board through his medical and scientific expertise and his knowledge of the health care environment and the scientific nature of Abbott's key research and development initiatives.

Roxanne Austin

Ms. Roxanne S. Austin serves as Independent Director of the Company. Ms. Austin is President and Chief Executive Officer of Austin Investment Advisors, a private investment and consulting firm, and chairs the U.S. Mid-Market Investment Advisory Committee of EQT Partners. Previously, Ms. Austin also served as the President and Chief Executive Officer of Move Networks, Inc., a provider of Internet television services. Ms. Austin served as President and Chief Operating Officer of DIRECTV, Inc. Ms. Austin also served as Executive Vice President and Chief Financial Officer of Hughes Electronics Corporation and as a partner of Deloitte & Touche LLP. Ms. Austin served on the Board of Directors of Telefonaktiebolaget LM Ericsson from 2008 to 2016. Ms. Austin currently serves on the Board of Directors of AbbVie Inc., Target Corporation, and Teledyne Technologies, Inc. Through her extensive management and operating roles, including her financial roles, Ms. Austin contributes significant oversight and leadership experience, including financial expertise and knowledge of financial statements, corporate finance and accounting matters.

Sally Blount

Ms. Sally E. Blount, Ph.D., serves as Independent Director of the Company. Ms. Blount has served as Dean of the J.L. Kellogg Graduate School of Management and the Michael L. Nemmers Professor of Management and Organizations at Northwestern University since July 2010. From 2004 to 2010, she served as the Vice Dean and Dean of the undergraduate college of New York University's Leonard N. Stern School of Business. Ms. Blount joined the faculty of New York University's Leonard N. Stern School of Business in 2001 and was the Abraham L. Gitlow Professor of Management and Organizations. Prior to joining NYU in 2001, Ms. Blount held academic posts at the University of Chicago's Graduate School of Business from 1992 to 2001. Ms. Blount currently serves on the Board of Directors of Ulta Beauty, Inc. As Dean of the J.L. Kellogg Graduate School of Management at Northwestern University and as the Vice Dean and Dean of the undergraduate college of New York University's Leonard N. Stern School of Business, Ms. Blount provides Abbott's Board with expertise on business organization, governance and business management matters.

Edward Liddy

Mr. Edward M. Liddy serves as Independent Director of the Company. Mr. Liddy served as a partner in the private equity investment firm Clayton, Dubilier & Rice, LLC from January 2010 to December 2015. At the request of the Secretary of the U.S. Department of Treasury, Mr. Liddy served as Interim Chairman and Chief Executive Officer of American International Group, Inc., a global insurance and financial services holding company, from September 2008 until August 2009. From January 1999 to April 2008, Mr. Liddy served as Chairman of the Board of the Allstate Corporation. He served as Chief Executive Officer of Allstate from January 1999 to December 2006, President from January 1995 to May 2005, and Chief Operating Officer from August 1994 to January 1999. Mr. Liddy currently serves on the Board of Directors of AbbVie Inc., 3M Company, and The Boeing Company. Through his executive leadership at Allstate and American International Group, and his board service at several Fortune 100 companies across a broad range of industries, Mr. Liddy provides valuable insights on corporate strategy, risk management, corporate governance and many other issues facing large, global enterprises. Additionally, as a former chief financial officer, audit committee chair at Goldman Sachs and 3M Company, and partner at Clayton, Dubilier & Rice, LLC, Mr. Liddy provides significant knowledge and understanding of corporate finance, capital markets, financial reports and accounting matters.

Nancy McKinstry

Ms. Nancy McKinstry serves as Independent Director of the Company. Ms. McKinstry has been the Chief Executive Officer and Chairman of the Executive Board of Wolters Kluwer N.V. since September 2003 and a member of its Executive Board since June 2001. Ms. McKinstry also serves on the Board of Accenture, the Board of Overseers of Columbia Business School, and the Board of Directors of Russell Reynolds Associates. Ms. McKinstry is also a member of the European Round Table of Industrialists. Ms. McKinstry served on the Board of Directors of Telefonaktiebolaget LM Ericsson (LM Ericsson Telephone Company) from 2004 to 2012. As the Chief Executive Officer and Chairman of the Executive Board of Wolters Kluwer N.V., Ms. McKinstry contributes global perspectives and management experience, including an understanding of key issues facing a multinational business such as Abbott's.

Phebe Novakovic

Ms. Phebe N. Novakovic serves as Independent Director of the Company. Ms. Novakovic has been Chairman and Chief Executive Officer of General Dynamics Corporation since January 1, 2013. Previously, she served as President and Chief Operating Officer from May 2012 to December 2012 and as Executive Vice President, Marine Systems of General Dynamics from May 2010 to May 2012. From May 2005 to April 2010, Ms. Novakovic served as its Senior Vice President—Planning and Development. She was elected Vice President of General Dynamics in October 2002 after joining the company in May 2001. Previously, Ms. Novakovic was Special Assistant to the Secretary and Deputy Secretary of Defense, and had been a Deputy Associate Director of the Office of Management and Budget. As a member of the Board of Directors and Chief Executive Officer of General Dynamics Corporation, Ms. Novakovic has strong management experience with a major public company, including significant marketing, operational and manufacturing experience, and contributes valuable insights into finance and capital markets. Her tenure with the Office of Management and Budget and as Special Assistant to the Secretary and Deputy Secretary of Defense enables her to provide government perspective and experience in a highly regulated industry.

Samuel Scott

Mr. Samuel C. Scott, III., serves as Independent Director of the Company. Mr. Scott retired as Chairman, President and Chief Executive Officer of Corn Products International in 2009. He served as Chairman, President, and Chief Executive Officer from February 2001 until he retired in May of 2009. He was President and Chief Operating Officer from January 1998 until February 2001. He was President of the Corn Refining Division of CPC International from 1995 through 1997, when CPC International spun off Corn Products International as a separate corporation. Mr. Scott currently serves on the Board of Directors of Bank of New York Mellon Corporation and Motorola Solutions, Inc. As the Chairman, President and Chief Executive Officer of Corn Products International, Mr. Scott acquired valuable business, leadership and management experience, including critical insights into matters relevant to a major public company and experience in finance and capital markets matters.

Daniel Starks

Mr. Daniel J. Starks serves as Independent Director of the Company. Mr. Starks served as the Chairman, President and Chief Executive Officer of St. Jude Medical, Inc., from 2004 until his retirement in January 2016, after which he served as its Executive Chairman of the Board until January 2017, when Abbott completed the acquisition of St. Jude Medical, Inc. Mr. Starks also served as President and Chief Operating Officer of St. Jude Medical, Inc. from 2001 to 2004 and as its President and CEO, Cardiac Rhythm Management Business from 1997 to 2001. Having served as St. Jude Medical's Executive Chairman and its Chairman, President and Chief Executive Officer, and having joined St. Jude Medical in 1996, Mr. Starks contributes not only comprehensive and critical knowledge of St. Jude Medical's operations, but also extensive business and management experience operating a global public company in a highly regulated industry.

Glenn Tilton

Mr. Glenn Fletcher Tilton serves as Independent Director of the Company. Mr. Tilton served as Chairman, President and Chief Executive Officer of UAL Corporation, and Chairman and Chief Executive Officer of United Air Lines, Inc., an air transportation company and wholly owned subsidiary of UAL Corporation, from September 2002 to October 2010. Mr. Tilton also served on the Board of United Continental Holdings, Inc. from 2001 to 2013 and served as its Non-Executive Chairman of the Board from October 2010 to December 2012. Mr. Tilton is also a Director of AbbVie Inc. and Phillips 66. Mr. Tilton also served on the Board of Directors of Lincoln National Corporation from 2002 to 2007, of TXU Corporation from 2005 to 2007, of Corning Incorporated from 2010 to 2012, and as Chairman of the Midwest for JPMorgan Chase & Co. and a member of its companywide Executive Committee from June 2011 to June 2014. Having previously served as Chief Executive Officer of UAL Corporation and United Air Lines, Non Executive Chairman of the Board of United Continental Holdings, Inc., Chairman of the Midwest for JPMorgan Chase & Co., Chairman, President, and Vice Chairman of Chevron Texaco, and as Interim Chairman of Dynegy, Inc., Mr. Tilton acquired strong management experience overseeing complex multinational businesses operating in highly regulated industries, as well as expertise in finance and capital markets matters.

Basic Compensation

Name Fiscal Year Total

Miles White

18,971,000

Brian Yoor

4,537,070

Michael Rousseau

18,808,600

Hubert Allen

4,868,540

Stephen Fussell

5,750,460

Robert Ford

4,701,910

Jaime Contreras

--

Eric Fain

13,330,800

Daniel Salvadori

4,088,490

William Osborn

305,939

John Stratton

63,000

Robert Alpern

331,466

Roxanne Austin

301,606

Sally Blount

306,736

Edward Liddy

294,606

Nancy McKinstry

286,939

Phebe Novakovic

290,939

Samuel Scott

306,939

Daniel Starks

254,939

Glenn Tilton

306,939
As Of  30 Dec 2017

Options Compensation